Pathfinder Cell Therapy, Inc. (PFND)
OTCMKTS · Delayed Price · Currency is USD
0.0000
0.00 (0.00%)
At close: Dec 29, 2025

Pathfinder Cell Therapy Revenue

Revenue
n/a
Revenue Growth
n/a
P/S Ratio
n/a
Revenue / Employee
n/a
Employees
1
Market Cap
667.00

Revenue Chart

History

Fiscal Year End Revenue Change Growth
Dec 31, 2014---
Dec 31, 201354.00K-60.00K-52.63%
Dec 31, 2012114.00K41.00K56.16%
Dec 31, 201173.00K--
Dec 31, 2010---
Dec 31, 2009 Pro Pro Pro
Dec 31, 2008 Pro Pro Pro

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition

Related Stocks

Company Name Revenue
U.S. Stem Cell 82.05K
Alzex Neuropharma 4.73M
RegeneRx Biopharmaceuticals 76.76K
GlobeImmune 6.21M
DNAPrint Genomics 1.93M
Revenue Rankings